Learning outcomes
By the end of this lesson you should be able to: recognise a dermatological emergency in the first minutes of a consultation and name the ones that kill; manage toxic epidermal necrolysis in the first 24 hours, including estimating the body surface area detached and applying SCORTEN; distinguish histaminergic from bradykinin-mediated angio-oedema and manage each airway; manage erythroderma and its fluid, temperature and cardiac consequences; recognise necrotising fasciitis, toxic shock syndrome, meningococcaemia and acute generalised pustular psoriasis; and apply the same initial framework — airway, breathing, circulation, withdrawal of the cause, temperature and fluids — to any of them.
Prerequisites
Lesson 8 for the vesicobullous diseases, drug reactions and toxic epidermal necrolysis, Lesson 4 and Lesson 10 for infections in the immunosuppressed, and Lesson 6 for eczema and erythroderma.
The big idea
The mechanism of death is shared. A skin that has lost its barrier loses litres of water and protein, cannot hold heat, cannot prevent infection and cannot regulate perfusion. That is why toxic epidermal necrolysis is managed like a major burn, why erythrodermic patients go into high-output cardiac failure and temperature failure, and why the principle for a necrotising soft-tissue infection is source control. In every case the first two actions are the same: stop the cause (the drug, the allergen, the tampon) and call for the right unit — burns, intensive care or surgery.
The emergencies and their first actions
| Emergency | Red flag | First action |
|---|---|---|
| Toxic epidermal necrolysis | Dusky or purplish painful macules with sheets of epidermal detachment and a positive Nikolsky sign, and mucosal erosions, days to a few weeks after a new drug | Withdraw the drug and never re-give it; admit to a burns or intensive care unit; estimate the detached surface area; warm the room; fluids, analgesia, nutrition, eye care and monitoring for sepsis |
| Anaphylaxis and angio-oedema | Urticaria with tongue, lip or laryngeal swelling, wheeze or hypotension; or bradykinin-type swelling with no urticaria and no itch | Assess the airway and call for help; intramuscular adrenaline for histamine-mediated reactions; stop the angiotensin-converting enzyme inhibitor permanently and manage the bradykinin pathway with a C1 inhibitor concentrate or icatibant |
| Necrotising fasciitis | Pain out of proportion to the visible skin, oedema beyond the erythema, crepitus, bullae, dusky skin, a greyish dishwater discharge and systemic toxicity | Resuscitate, give broad-spectrum antibiotics with clindamycin, and call the surgical team for immediate debridement; imaging must not delay the operation |
| Toxic shock syndrome | Fever with a generalised rash, hypotension and multiorgan involvement, and desquamation of the palms and soles a week or two later | Remove the source (a tampon, a surgical pack, a foreign body), give a beta-lactam with clindamycin, treat the shock, and consider intravenous immunoglobulin |
| Meningococcaemia | Fever with a spreading, non-blanching petechial or purpuric rash, meningism or shock | Do not delay: give parenteral ceftriaxone or benzylpenicillin immediately and transfer; purpura fulminans will need surgical debridement and grafting |
| Severe cutaneous adverse drug reaction | Facial oedema with a widespread morbilliform rash, fever and eosinophilia (DRESS); or sterile pustules on erythema within 24 hours of a drug (AGEP) | Withdraw the drug, check liver and renal function, full blood count and cardiac enzymes, and give prednisolone for DRESS; support the mild AGEP and expect desquamation |
| Erythroderma | Confluent erythema over more than 90 per cent of the body surface with temperature or haemodynamic instability | Correct fluids and temperature, treat the cause, screen for infection and exclude a cutaneous T-cell lymphoma |
| Acute generalised pustular psoriasis | Fever with sheets of sterile pustules on fiery erythema, leucocytosis and sometimes hypocalcaemia | Give ciclosporin or a fast-acting biologic, supportive care, fluids and electrolytes, and treat the trigger |
| Herpes zoster in the immunosuppressed or in the ophthalmic division | Vesicles on the tip of the nose or forehead, or a disseminated rash in an immunosuppressed patient | Start oral or intravenous antivirals immediately, refer to ophthalmology for eye disease, and manage the underlying immunosuppression |
NoteWhen in doubt, ask three questions of any acute rash: is the skin painful or peeling, are the mucosae involved, and did the patient start a new drug in the last eight weeks? Pain, mucosal involvement and a recent drug together predict toxic epidermal necrolysis and DRESS, and all three demand immediate escalation.
Toxic epidermal necrolysis: the burns-unit disease
Toxic epidermal necrolysis is the most severe cutaneous adverse drug reaction, defined as detachment of more than 30 per cent of the body surface area with mucosal involvement; Stevens-Johnson syndrome is the same disease at less than 10 per cent, and the intermediate form is called the overlap. Mortality rises with the area detached and with age, and the effective treatment is organised supportive care in a burns or intensive care unit over 3 to 4 weeks.
| SCORTEN risk factor | Threshold |
|---|---|
| Age | Over 40 years |
| Heart rate | Over 120 beats per minute |
| Malignancy | Any |
| Body surface area detached at presentation | More than 10 per cent |
| Serum urea | More than 10 millimoles per litre |
| Serum glucose | More than 14 millimoles per litre |
| Serum bicarbonate | Less than 20 millimoles per litre |
Each factor scores one point; a score of 0 or 1 predicts low mortality, 2 warrants transfer to a burns unit, and 5 or more predicts a mortality over 90 per cent. Estimate the detached surface area with the rule of nines, or use the patient's palm and fingers together as about 1 per cent. The supportive package is a warm room of 28 to 30 degrees to prevent hypothermia, fluid replacement guided by urine output and perfusion (with a urinary catheter), early enteral nutrition, analgesia, gentle handling and non-adherent dressings, thromboprophylaxis, daily eye examination with preservative-free lubricants and ophthalmology input, monitoring for infection without prophylactic antibiotics, and consideration of ciclosporin 3 to 5 mg per kg, intravenous immunoglobulin 2 to 3 g per kg or a tumour necrosis factor inhibitor. Systemic corticosteroids are avoided because they increase sepsis, and thalidomide is contraindicated because it increases mortality.
Angio-oedema: two diseases, one airway
| Feature | Histaminergic (mast cell) | Bradykinin-mediated |
|---|---|---|
| Presentation | Urticarial wheals, itch, flushing, sometimes bronchospasm and hypotension | Non-pitting swelling of the face, lips, tongue and larynx, and of the bowel wall, with pain and colic but no itch and no wheal |
| Causes | Allergy (food, drug, latex, venom) and physical triggers; most cases are self-limiting | Angiotensin-converting enzyme inhibitor (any patient at any time after starting), hereditary C1 inhibitor deficiency, and acquired deficiency in lymphoproliferative disease |
| Investigation | History, examination and tryptase during the episode | C4 first (low), then C1 inhibitor level and function; consider whenever there is recurrent swelling, abdominal attacks or a family history |
| Management | Airway, intramuscular adrenaline, oxygen, intravenous antihistamine and hydrocortisone, and withdrawal of the trigger | Airway; stop the angiotensin-converting enzyme inhibitor permanently and substitute later with caution; C1 inhibitor concentrate, icatibant or ecallantide for attacks; danazol or tranexamic acid for prophylaxis. Adrenaline, antihistamines and corticosteroids do not work |
Watch outIn any swelling of the tongue, floor of the mouth or larynx, assess the airway before the rash. Hoarseness, stridor, difficulty swallowing, tongue swelling or a sensation of the throat closing are indications for immediate anaesthetic and ENT involvement — the airway is the only structure that can kill within minutes, and the diagnosis can wait.
Erythroderma
Erythroderma is total skin failure: more than 90 per cent of the surface is red and scaling, with heat loss, a hypermetabolic state, capillary leak with protein loss and oedema, cardiac strain and the risk of secondary infection. The causes are psoriasis (the commonest in the elderly, often from abrupt withdrawal of systemic steroids or methotrexate), atopic and contact dermatitis, drug reactions, cutaneous T-cell lymphoma (Sezary syndrome, which presents with intense itch, alopecia, lymphadenopathy and atypical cells on the blood smear), pityriasis rubra pilaris, and idiopathic cases. Management is admission: keep the room at 28 to 30 degrees to prevent hypothermia, replace fluid and protein losses, monitor the fluid balance carefully because over-resuscitation causes pulmonary oedema, keep the skin moist with emollient and wet wraps, apply a moderate topical corticosteroid or the systemic agent appropriate to the diagnosis, treat infection, watch for high-output failure and thromboembolism, and biopsy and refer if the cause is not obvious — because Sezary syndrome is diagnosed years late when every erythroderma is called eczema.
Necrotising soft tissue infection and toxic shock
Necrotising fasciitis is a surgical diagnosis. Type I is polymicrobial including anaerobes (and includes Fournier gangrene of the perineum), type II is group A streptococcus with or without staphylococcus, and type III is marine Vibrio in a patient with liver disease. The clinical clue is pain disproportionate to the findings, followed by skin necrosis, bullae, crepitus and a greyish dishwater discharge as the infection tracks along fascial planes, in a patient who becomes disproportionately unwell. Computed tomography supports but must not delay the operating theatre: the treatment is urgent resuscitation, broad-spectrum antibiotics with clindamycin to suppress toxin production, and immediate radical debridement with planned re-exploration. Mortality is high, and intravenous immunoglobulin is used in streptococcal toxic shock syndrome. Toxic shock syndrome presents with fever, a generalised macular rash, hypotension, multiorgan dysfunction and late desquamation of the palms and soles from staphylococcal TSST-1 or streptococcal pyrogenic exotoxin; treatment is removal of the source, antibiotics with clindamycin, shock management and immunoglobulin in refractory cases.
NoteMeningococcaemia is a dermatological emergency in disguise: a spreading purpuric rash that does not blanch on pressure, in a febrile and toxic patient, must be treated with parenteral ceftriaxone or benzylpenicillin before any investigation, and purpura fulminans may need surgical debridement and skin grafting.
Common mistakes
Watch outContinuing a culprit drug to finish the course. In Stevens-Johnson syndrome and toxic epidermal necrolysis every additional dose increases the area detached and the mortality. Stop the drug, document the allergy prominently, and never re-give it or a chemically related agent.
Watch outSending an angio-oedematous patient home without an airway assessment and without checking for an angiotensin-converting enzyme inhibitor. ACE-inhibitor angio-oedema will not respond to adrenaline or antihistamines, and it can occur years after the drug was started.
Watch outOver-resuscitating the erythrodermic patient. Erythrodermic skin loses litres of water and protein, but capillary leak makes uncontrolled fluid replacement dangerous: measure the fluid balance, replace the calculated losses and re-evaluate hourly, because both dehydration and pulmonary oedema kill.
Watch outWaiting for a computed tomography scan before sending a suspected necrotising fasciitis to theatre. Imaging confirms the decision after the operation; it is not a permission slip before it. Laboratory scores support the clinical decision but do not replace it.
Check your understanding
A patient on ramipril for three years develops sudden painless swelling of the lip and tongue with no urticaria and no itch, and now has a hoarse voice. What is happening and what must you do first?
A patient has confluent erythema over the whole body with fever and a heart rate of 120. What complications are you watching for?
What are the first three actions in a patient with painful dusky macules, a positive Nikolsky sign and oral erosions four days after starting co-trimoxazole?
Multiple choice
Which of the following is NOT part of the standard management of toxic epidermal necrolysis?
A patient with no urticaria and no itch has recurrent facial and abdominal swelling, and a brother has the same problem. Which investigation confirms the likely diagnosis?
Which clinical feature should most urgently raise the possibility of necrotising fasciitis?
A patient with erythroderma, high-output cardiac failure and hypothermia should have which of the following?
Summary and next
A dermatological emergency is one in which skin fails as an organ: the barrier, thermoregulation, fluid retention and immune containment are lost together, and the first moves are always the same. Toxic epidermal necrolysis needs withdrawal of the culprit drug, transfer to a burns unit, SCORTEN, and careful supportive care without systemic corticosteroids; an antibiotic and surgical source control for necrotising infection; adrenaline for histaminergic angio-oedema and a bradykinin pathway treatment for the ACE-inhibitor and hereditary forms; and warmth, fluids and nutrition for erythroderma. The skin signs that predict them — pain, mucosal involvement, a positive Nikolsky sign, a non-blanching rash and a drug started in the last eight weeks — are the ones you must be able to see from the end of the bed.
This is the last lesson of DERM 307. The eleven concepts of this course — structure and function, examination and morphology, the bacterial, fungal, viral and infestational dermatoses, leprosy and the sexually transmitted infections, eczema, the papulosquamous disorders, vesicobullous disease and drug eruptions, pigmentary disorders, the genodermatoses and HIV-related disease, and the emergencies — form the whole of a general dermatology curriculum, and each is assessable by the SBA items in the assessment bank.